Perspective Therapeutics Inc
ISR
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-24,751,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.4 |
| Beta | 0 |
| Outstanding Shares | 103,604,000 |
Return
| Return on Equity | -31.99% |
|---|---|
| Return on Assets | -27.05% |
| Return on Invested Capital | 2.00% |
Valuation & Multiples
| P/E Ratio | -3.67 |
|---|---|
| PEG | -8.33 |
| Price to Sales | - |
| Price to Book Ratio | 0.13 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.27 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.18 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 83,300▲ 535.88% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 49.24%▼ 8.00% |
|---|---|
| Total Invested | $14.05M▼ 13.97% |
| Investors Holding | 117▲ 13.00% |
ESG Score
No data
About Isoray, Inc.
CEO: Dwight Babcock